Cure My Disease

Don't miss your cure!

 Log in / Sign up

New gum bone fix tested for better dental implants

NCT ID NCT07424573

Disease control Sponsor: Naira elnagar Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests two ways to build up a narrow upper jawbone so dental implants can be placed. Twenty adults with a thin jawbone in the front upper area will receive either a piece of the patient's own bone or a special fibrin block. The goal is to see which method gives more bone width and less bone loss over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

20 people

The number who actually took part.

Started

May 2024

Expected to finish

Apr 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Maxillary narrow ridge in the esthetic anterior zone (about 4-5 mm in width). * Bone height allows the insertion of at least 8 mm of implant length without the need for vertical augmentation. * Patient aged 18-45 years old. * The presence of enough amount of keratinized gingiva as well as enough space for prosthesis rehabilitation. * Favorable occlusion without presence of parafunctional habits. * Cooperative patient with high motivation and acceptable oral hygiene. * Patients are medically free from systemic diseases or drugs that absolutely contraindicate implant surgery. * Patients able to comply with the required recall visits. Exclusion Criteria: * Local and / or systemic conditions that may affect passively the clinical procedure or results. * Heavy smokers(\>20 cigarettes/d).(1) * Alcohol or drug abuse. * Patients with parafunctional habits (bruxism and clenching). * Pregnancy. * Uncooperative patients.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Extented platelet rich fibrin block are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Extented platelet rich fibrin block

Contacts and locations

Locations

  • Mansoura University

    Al Mansurah, Egypt